ALB and neoplasm: For example, a patient with an albumin of 45 g/L, a bilirubin of 7 μmol/L, an AFP of 5789 U/L, the largest tumour measuring 5.9 cm with macrovascular invasion, but without extrahepatic spread, will have a predicted survival of 87%, 70%, 44% and 19% and 9% at 3, 6, 12, 24 and 36 months, respectively.